Follicular lymphoma (FL), a common lymphoma in adults, occurs rarely in pediatric and young adult patients. Most pediatric cases have been described as grade 3, but the criteria to distinguish the pediatric variant of FL (PFL) from usual FL (UFL) seen in adults are not well defined. We undertook a study of FL in patients under the age of 30. We identified 63 cases, which were analyzed by morphology, immunohistochemistry, and polymerase chain reaction analysis of IGH@ and IGK@ clonality. These data were correlated with clinical findings including stage, treatment, and outcome. Among the 63 cases, 34 cases were classified as PFL: 22 presenting in lymph nodes, 8 in the Waldeyer ring, and 4 in the testis. Clonal immunoglobulin gene rearrangement was detected in 97% of PFL cases, but fluorescence in situ hybridization analysis showed an absence of the BCL2/IGH@ translocation in all cases tested. Twenty-nine cases were classified as UFL, 28 of which presented in lymph nodes. The nodal PFLs were observed exclusively in male patients in both children and young adults with a median age of 15 years. They showed marked head/neck predilection, blastoid cytologic features with a high proliferation rate, lack of BCL2 protein and t(14;18), low clinical stage at presentation, and good prognosis. PFLs involving the Waldeyer ring were distinguished by MUM1 expression, 50% (3/6) of which carried IRF4 breaks. BCL2 expression was common (63%) in the absence of BCL2/ IGH@ translocation. UFLs were more common in female patients, exclusively in young adults (median age, 24 y), with no cases reported in patients under the age of 18. Twenty-five of 29 cases were of grade 1-2, and 4 cases were classified as grade 3A. They exhibited a higher clinical stage at presentation. Eightythree percent expressed BCL2. Our results indicate that histologic and immunophenotypic criteria can reliably separate PFL and UFL and that UFL is exceptionally rare in the pediatric age group. PFL associated with particular anatomic sites have distinctive features and should be evaluated separately in future clinical and biological studies.
F ollicular lymphoma (FL) is the second most common lymphoma worldwide. It mainly affects adults and rarely occurs in the pediatric population and young adult patients. 1 Pediatric follicular lymphoma (PFL) is a newly recognized variant of FL included in the 2008 WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. 1 Limited studies have reported on the histologic, molecular, and clinical features of FL in young patients. [2] [3] [4] [5] [6] [7] [8] PFL is reported to be characterized by high histologic grade and the lack of BCL2 protein expression and t (14;18) . Clinically, PFL predominantly occurs in male individuals, often presents with localized disease, and carries good prognosis. [3] [4] [5] Currently, the pathogenesis of this entity is largely unknown, and differences between nodal PFL and PFL in other anatomic sites have not been explored. Although differences in cytologic grade have been noted with usual FL (UFL) as seen in adults, PFL is often a diagnostic challenge, and more precise histologic criteria have not been defined.
Although a conservative approach toward FL in pediatric patients had been proposed by Atra et al in 1998, 2 the optimal clinical management remains unclear. Furthermore, clinicopathologic features of FL in young adult patients have not been extensively studied. In this study, we examined the histologic features, immunophenotypic profiles, immunoglobulin gene rearrangement by polymerase chain reaction (PCR), cytogenetic characteristics by fluorescence in situ hybridization (FISH), and the clinical follow-up data of 63 FL cases in pediatric (r18 y old) and young adult (19 to 29 y old) patients. We used both the World Health Organization (WHO) criteria and new observations to separate PFL from UFL in the young adult population and to better delineate the clinical, histologic, and immunophenotypic spectrum of PFL. These results will be of value in guiding the diagnosis and management of FL and the PFL variant.
MATERIALS AND METHODS

Case Selection
An electronic search of the pathology database at the National Cancer Institute, National Institutes of Health (Bethesda, MD), was conducted for cases diagnosed as FL, or those that were consistent with FL, restricted to the age group of less than 30, from 2000 to 2011. Sixty-eight cases with material available for review were identified. Five cases were excluded for the following reasons: (1) revised diagnosis of follicular hyperplasia (1 case); (2) revised diagnosis of marginal zone lymphoma (1 case); (3) excluded on the basis of a component of diffuse large B-cell lymphoma (DLBCL, 3 cases). Sixty-three cases comprised the final study cohort. Cases of nodal FL (51) were classified according to the 2008 WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues as PFL or UFL, without knowledge of the patient's age or other clinical data. 1 Criteria for nodal PFL included large expansible follicles, dim to absent BCL2 expression, and a high proliferative rate. This study was approved by the Institute Review Board of the National Cancer Institute. Clinical information and follow-up data were obtained from submitted patient records or referring physicians in accordance with medical practice guidelines. Ten pediatric nodal marginal zone lymphoma (PNMZL) cases were reviewed concurrently to compare histologic features of PFL with those of PNMZL. 9
Histology and Immunohistochemistry
The morphologic and immunophenotypic features were studied on formalin-fixed and paraffin-embedded (FFPE) tissue sections of the diagnostic biopsies. Immunohistochemical stains were performed using an automated immunostainer (Ventana Medical Systems Inc., Tucson, AZ) as described previously. 10 In brief, antigen retrieval was performed using a Tender Cooker (Nordicware, Minneapolis, MN) with citrate buffer. The immunohistochemical panel included CD20, CD3, CD10, BCL2 (clone 124), BCL6, MUM1, IgD, CD21, CD23, MIB1 (Ki-67), and programmed death 1 (PD-1; CD279). Appropriate controls were included in all cases. BCL2 and CD10 were scored as positive if >50% of tumor cells exhibited staining; for BCL6 and MUM1 the required value was 30%. The E17 clone reactive with the mutated form of BCL2 (Epitomics) was examined in a subset of the cases, negative for BCL2 with clone 124 (Dako). 11 
PCR Analysis of Immunoglobulin Gene Rearrangement
PCR analysis of immunoglobulin gene rearrangement was performed as described previously. 10 Genomic DNA was extracted from FFPE tissue sections using QIAamp DNA FFPE tissue kit (Qiagen Inc., Valencia, CA) according to the manufacturer's instructions. For immunoglobulin heavy chain (IGH@) clonality assays, framework 3 and framework 2 were amplified by PCR using consensus primer sets as reported by Segal et al 12 and Ramasamy et al, 13 respectively. For k light chain (IGK@) clonality assays, IGK@ was amplified by PCR using ABI Fluorescence Detection Kit (In VivoScribe Technologies Inc., San Diego, CA) according to the manufacturer's instructions. After amplification, the PCR products were analyzed using ABI 3130xl Genetic Analyzer (Applied Biosystem), and the results were interpreted on the basis of the criteria developed in the laboratory. 10 The tissue biopsies (lymph node, tonsil, testis) were extensively involved by the abnormal follicles, comprising the vast majority of the B cells present; thus, enrichment for tumor cells was not required. In a single tonsillar case (case 8), focal involvement was present; in this case macrodissection of the involved portion was performed to enrich for tumor DNA.
Construction of Tissue Microarray
For PFL cases with available tissue blocks, a tissue microarray (TMA) was constructed to facilitate analysis of interphase cytogenetics, as described previously. 14 Representative tumor areas were selected on the basis of the corresponding hematoxylin and eosin (H&E) slides and marked directly on the donor block. Two tissue cores (diameter 1.5 mm) were transferred from the selected region of each donor block and arrayed into the recipient block using TMArrayer (Pathology Devices, Westminster, MD). Following the TMA construction, 5-mm-thick sections were cut with a microtome. An H&E stain was obtained to confirm inclusion of diagnostic tissue.
FISH Analysis
Interphase FISH analysis for the detection of breaks or gene fusion affecting the IGH@, BCL2, BCL6 (LSI dual-color break-apart probes and IGH@-BCL2 dualcolor dual-fusion translocation probe; Vysis-Abbott, IL, USA) and IRF4 loci was performed on FFPE sections from TMA or whole tissue sections of the PFL cases, as described previously. 15 Breaks of the CBFA2T3 gene, recently described to be translocated in pediatric germinal centerderived lymphomas, were also investigated using previously described probes. 16 FISH analysis for the detection of IGH@, BCL6, and IRF4 breaks was performed on each case that had material available, whereas FISH analysis for BCL2 and CBFA2T3 breaks was performed only on the cases that contained IGH@ breaks. For the cases harboring breaks in both IGH@ and IRF4 loci, IGH@-IRF4 gene fusion was confirmed by using fusion probes. 16 
RESULTS
Histologic and Immunophenotypic Findings
Thirty-four of 63 FL cases were classified as PFL (Table 1) , and 29 cases were classified as UFL ( Table 2 ).
Pediatric Follicular Lymphoma
Cases diagnosed as PFL presented in the lymph nodes (22 cases), the Waldeyer ring (tonsils or tonsils and adenoids) (8 cases), and testis (4 cases). Differences in the histologic and immunophenotypic features were noted, depending on the anatomic site, and therefore these groups will be separately described. All cases of PFL would be considered grade 3, on the basis of the proportion of centroblasts/blastoid cells.
PFLs involving the tonsils ( Fig. 1 ) were characterized by large, closely packed, expansile follicles composed predominantly of centroblasts (3/8 cases, Fig. 2A ) or intermediate-sized blastoid cells (5/8 cases, Fig. 2B ). The blastoid cells had round to oval nuclei, finely clumped chromatin, small nucleoli, and scant cytoplasm. A "starry-sky" appearance, a feature commonly seen in reactive follicles, was sometimes maintained. The subset involving the tonsils was more likely to be positive for BCL2 protein (5/8, 63%) , and notably all cases tested were positive for MUM1 (Table 3 ). CD10 was expressed in 63% (5/8) and BCL6 was positive in 100% (8/8) of the cases, confirming a germinal center derivation. BCL6positive and CD10-positive cells were confined to the follicles. One case showed evidence of k light chain restriction by immunohistochemistry.
PFL involving the lymph nodes showed effaced nodal architecture by large ill-defined follicles with attenuated lymphoid cuffs ( Fig. 3) . A prominent starry-sky pattern was present in all cases. The follicles were often serpiginous or irregularly shaped. Occasional nodal PFL cases showed more uniform, closely packed follicles, similar to those seen in tonsillar PFL cases (Supplemental Digital Content 1, http://links.lww.com/PAS/A150). A peripheral rim of paler cells suggesting monocytoid differentiation was sometimes present but was a minor component. The cytologic composition was similar in all cases and was dominated by monotonous, small-sized to medium-sized blastoid cells with round to oval nuclei, finely clumped chromatin, small nucleoli, and scant cytoplasm (Figs. 2C, D). Typical centroblasts with peripheral membrane-bound nuclei were infrequent. Centrocyte-like cells were sometimes present but had somewhat dispersed chromatin.
PFL in the lymph nodes were consistently and strongly positive for CD10 (100%), with CD10 highlighting the often irregular follicle centers ( Fig. 3 ). BCL6 was positive as well, with only 18% showing any expression of BCL2 protein, which was weakly positive. Eight cases of nodal PFL negative for BCL2 with clone 124 were examined with clone E17 and were negative as well. CD10positive and BCL6-positive cells did not extend beyond the follicles. MUM1 was positive in 1/18 (5.5%) nodal PFL cases; this case was also positive for CD10, BCL6, CD5, and l light chain. Among the tonsillar or nodal MUM1positive cases, cytologic features of plasmacytoid differentiation were not observed, even in the presence of light chain restriction by immunohistochemistry. Interfollicular B cells were not markedly increased, helping in the distinction from PNMZL. In 4 cases with marginal zone differentiation, a perifollicular rim of B cells could be identified.
PFL involving the testes contained back-to-back atypical small follicles composed predominantly of centroblasts infiltrating between seminiferous tubules (Supplemental Digital Content 2, http://links.lww.com/PAS/ A151). The follicles lacked well-defined mantle cuffs and did not show polarization. All cases were negative for BCL2 and MUM1 but were positive for BCL6 and CD10 in 4/4 (100%) and 3/4 (75%) cases, respectively. The follicles had a back-to-back arrangement, but interfollicular B cells beyond the follicles were not present. The follicular structures in all cases of PFL were highlighted by stains for CD21 and CD23. IgD identified thin and attenuated mantle zones. Tumor cells were negative for IgD. All PFL cases showed a high (Z75%) or moderate to high (50% to 75%) proliferation rate assessed by MIB1 stain.
Usual Follicular Lymphoma
Twenty-nine cases were diagnosed as UFL, 25 of which were classified as grade 1-2 and 4 as grade 3A. No cases of grade 3B were identified. All cases but 1 presented in the lymph node; 1 case was diagnosed in the thyroid, but the patient had disseminated disease. The histologic features were similar to those of adult UFL, in which the normal architecture was effaced or partially effaced by closely packed atypical follicles that showed absent or attenuated mantle cuffs and lack of polarity (Supplemental Digital Content 3, http://links.lww.com/ PAS/A152). A "starry-sky" appearance was no longer present. Centrocytes comprised the majority of the cells present in the grade 1-2 UFL cases, whereas >15/HPF centroblasts were present in grade 3A UFL cases. However, nodal UFL lacked the monotonous blastoid cytology that dominated nodal PFL.
All cases were positive for CD20 and BCL6. Of UFLs classified as grade 1-2, 100% (21/21) were CD10(+) and 83% (20/24) were BCL2(+). All but 2 grade 1-2 UFL cases showed low (r25%) or low to moderate (25% to 50%) proliferation rates by MIB1 stain, with higher rates seen in 2 cases. Of the 4 grade 3A UFL cases, 2 of 4 (50%) were CD10(+), and 2 of 3 (66.7%) cases tested were BCL2(+). All grade 3 UFL cases showed a high proliferation rate (>75%).
Pediatric Nodal Marginal Zone Lymphoma
Ten PNMZL cases were reviewed concurrently to compare the morphologic features between PFL and PNMZL ( Table 4 ). The cases showed characteristic Residual hyperplastic germinal centers maintained a starry-sky appearance, showed evidence of polarization best visualized with immunohistochemistry for Ki-67, and had a heterogenous cellular composition. The follicles were widely spaced, with less prominent CD10 positivity.
PD-1 Staining Pattern
To further facilitate the distinction between PFL and PNMZL, staining for PD-1 (CD279) was performed on PFL (24), UFL (16) , and PNMZL (9) cases. Distinctive patterns of PD-1 staining in the follicles were observed among tonsillar PFL, nodal PFL, nodal UFL, and PNMZL cases (Supplemental Digital Content 5, http:// links.lww.com/PAS/A154). In reactive follicles PD-1positive lymphocytes were abundant and more numerous in the light zone. This polarity was absent in the atypical follicles involved by PFL, UFL, and PNMZL. Generally, tonsillar PFL cases showed absent or a few scattered PD-1-positive cells. PD-1-positive cells were somewhat more frequent in nodal PFL, but tended to be concentrated in the periphery, giving an impression that these cells were pushed aside by the neoplastic cells. PD-1-positive cells were more abundant in the germinal centers of PNMZL, as compared with nodal PFL. UFL cases showed large numbers of PD-1-positive cells with a loss of polarity in the atypical follicles in comparison with that seen in hyperplastic follicles.
PCR and FISH Findings
A majority of the PFL cases demonstrated clonal immunoglobulin gene rearrangement on PCR analysis ( Table 3 ). The percentage of positive cases varied slightly among different anatomic sites, but the average rate ). An arrow indicates a follicular dendritic cell nucleus, which is similar in nuclear diameter to the neoplastic cells. C, Small-sized to medium-sized blastoid cells in some nodal PFLs (case 18) resembled centrocytes but exhibited a high proliferative rate with more dispersed chromatin. D, In most cases of nodal PFL the blastoid cells were medium to large, with finely clumped chromatin and small nucleoli (case 22), as compared with centroblasts shown in A.
of positivity was 97%. Four cases were negative with primers to Framework2 and Framework3 but positive with primers to the IGK@ gene segments.
FISH analysis to identify breaks in the IGH@, IRF4, and BCL6 loci was performed on FFPE sections of the PFL cases with available material. FISH analysis for One of the cases tested also showed an IGH@ break, and an IGH@-IRF4 fusion was confirmed by FISH ( Fig. 4 ). FISH analysis for IGH@ breaks could not be performed on the third case because of technical reasons. None of the PFL cases had BCL2, BCL6, or CBFA2T3 breaks.
Clinical Findings
The clinical data of the FL cases are summarized in Tables 1, 2 , and a comparison of the features between UFL and PFL is summarized in Table 5 . The PFL cases occurred in both pediatric and young adult patients with marked male predominance (M:F = 29:5) and a median age of 14 years (age range, 3to 25 y) (Tables 1, 5). All of the Waldeyer ring and testicular PFL cases were from pediatric patients, whereas 68% (15/22) of the nodal PFL cases were in the pediatric age group (age range, 3 to 18 y), and 32% were young adult patients (age range, 19 to 25 y). Nodal PFL was seen exclusively in male in-dividuals, and presented predominantly in the head/neck region (77%). Four PFL cases showed a concurrent DLBCL component (2 Waldeyer ring cases, 2 nodal cases). All PFL cases presented with localized disease and were clinical stage I (E) or II (E). The treatment regimens varied among the patients, including surgical excision only and excision with chemotherapy with or without local radiation. The components of the chemotherapy regimens also varied, but RCHOP (R, rituximab; CHOP, cyclophosphamide, adriamycin, vincristine, prednisone) was the most common regimen. All PFL patients achieved complete remission and showed no evidence of disease upon completion of treatment for various lengths of follow-up periods. The median follow-up period was 18 months (ranging from 1 to 120 mo). A few patients achieved long-term disease-free survival (patients 2, 9, and 25) after surgical excision only. Several recently diagnosed PFL patients preferred to be managed by surgical excision with close clinical follow-up.
Twenty-nine of the 63 cases were classified as UFL, including 25 grade 1-2 cases and 4 grade 3A cases (Tables 2, 5 ). The median age of this group was 24 years (range, 18 to 29 y) with a female predominance (M:F = 9:20). Interestingly, all 4 grade 3A UFL cases were diagnosed in female individuals. Notably no case of UFL was diagnosed in patients under the age of 18. All UFL cases but 1 were diagnosed in lymph node biopsies. The single case with extranodal involvement (thyroid) had disseminated disease (case 39). Seventy-four percent of the patients presented with multiple sites of lymphadenopathy with or without hepatosplenomegaly and/or presented as stage III or VI disease. For the cases that had IGH@-IRF4 fusion is shown using a locus-specific probe consisting of BAC clones labeled in spectrum orange (IRF4) and spectrum green (IGH@). The IGH@-IRF4 fusion is a reciprocal fusion, which in most cells will display 2 fusion signals (arrows). The presence of a single fusion signal in 1 cell (right arrow) is likely related to sectioning artifacts or differences in the focal plane. 
DISCUSSION
In this study we analyzed the clinicopathologic features of FL in pediatric and young adult patients. Using published criteria and new observations based on our analysis of these cases, we recognized 2 groups-UFL, resembling FL as seen in older adults, and PFL, lesions with distinctive histologic, immunophenotypic, and molecular features. Clinically, the UFL cases were seen exclusively in young adult patients, with no case diagnosed in patients under the age of 18. Patients with UFL showed a female predominance and had more advanced clinical stage at presentation. In contrast, the nodal PFL cases were seen in both pediatric and young adult patients, exclusively in male individuals, with a predilection for the head/neck region and low clinical stage at presentation. All of the PFL patients achieved complete remission following various treatment regimens, including surgical excision alone. These data suggest that PFL is a localized disease with good prognosis. For these patients, "Watch and wait" may be the best course of action after surgical excision, as previously suggested. 2 PFL and UFL show significant differences in clinical presentation and appear to differ in clinical outcome. Therefore, correct pathologic diagnosis is essential in guiding the optimal clinical management. In addition to the recognized architectural and cytologic features of nodal PFL delineated in the WHO classification (broad expansile follicles, high histologic grade), our study highlighted more subtle differences in the cytologic composition. Although PFL cases have been generally considered as grade 3 on the basis of a high proliferation rate, we observed that the neoplastic cells in nodal PFL were neither typical centrocytes nor centroblasts in most cases. The cells were often medium in size, monotonous in cytologic composition, with dispersed chromatin and inconspicuous nucleoli. This blastoid appearance correlated with a high proliferative rate. Understandably these cases have been categorized as grade 3, but diagnosis is facilitated by the appreciation of these distinctive cytologic features.
At times, making the distinction between nodal PFL and florid follicular hyperplasia with monotypic light chain expression and clonal immunoglobulin gene rearrangement by PCR 17 can be extremely difficult. The retained "starry-sky" appearance characteristically seen in nodal PFL cases further complicates the matter. In these situations, recognition of a monotonous, blastoid cytologic composition without polarization or typical centroblasts and centrocytes is helpful. The extent of the architectural alteration is also useful. PCR for detection of a clonal B-cell population appears to be a very sensitive test in PFL, a finding enhanced by the use of multiple primer sets. 18 Four cases negative for clonality by PCR with primers to the immunoglobulin heavy chain genes were positive when k probes were also used.
A notable observation was uniform positivity for MUM1 in all evaluable cases of PFL involving the Waldeyer ring. In contrast, MUM1 was expressed in only 5.5% of nodal PFL and in no case of testicular PFL. All of the MUM1-positive cases expressed BCL6, and 57% expressed CD10 (4/7, Table 6 ). BCL2 protein was expressed in 63% of the tonsillar cases as well. Prominent cytologic features of plasmacytic differentiation were not evident on H&E sections, and restricted light chain expression was rarely observed.
In view of the frequent expression of MUM1, we were interested in examining PFL for breaks involving IRF4/MUM1. Of the Waldeyer ring cases tested, IRF4 breaks were detected in 3 of 6 cases, and an IGH@/IRF4 fusion was confirmed in 1 of 2 cases tested. These data suggest that although IGH@/IRF4 fusion may represent 1 possible mechanism for the upregulation of MUM1 expression, other mechanisms probably also exist. Recent studies have highlighted the significance of MUM1 expression in B-cell lymphomas in children and young adults. Salaverria et al 15 identified recurrent IGH@/IRF4 Sixteen of the 20 positive cases in the published study were diagnosed in patients younger than 30 years of age and with frequent involvement of the Waldeyer ring (80%) as in our study. Both series identified coexpression of MUM1 with BCL6, which is an aberrant immunophenotype, as these proteins are reciprocally expressed in normal germinal centers. 19 Salaverria et al 15 also reported that the cases harboring an IGH@/ IRF4 translocation had frequent alterations in the BCL6 locus, including breaks and mutations. Although we did not identify chromosomal breaks in the BCL6 gene in any of our PFL cases, we did not perform sequence analysis to determine whether there were mutations in the BCL6 gene resulting in disruption of the BCL6-IRF4-PRDM1 regulatory pathway.
Originally identified by cloning the chromosomal breakpoints of a multiple myeloma cell line with t(6;14), the IRF4 gene is a member of the interferon regulatory factor family of transcriptional factors. MUM1 shows a biphasic expression pattern in B cells;-that is, it is expressed in immature B cells in bone marrow, absent in centroblasts of the germinal centers, and is again expressed in a subset of centrocytes in the light zone of germinal centers and plasma cells. 14, 20 It is generally believed that the expression of IRF4/MUM1 and BCL6 in B cells is mutually exclusive in normal germinal centers, but the positive cases of PFL aberrantly coexpressed both proteins. 21 UFL typically lacks MUM1 expression. 1 However, the reported positive cases are usually CD10 negative, of high histologic grade, clinically more aggressive, and interestingly occur in an older patient population. 22 In comparison with PFL in other anatomic sites, several notable differences were observed in PFL involving the Waldeyer ring. In addition to uniform positivity for MUM1, these cases were more often BCL2 positive (63%), had a higher frequency of IGH@ breaks (50%), and lacked a male predominance. These data suggest that PFL of the Waldeyer ring may have a different molecular pathogenesis from other forms of PFL.
As expected, the nodal PFL cases in our series were generally negative for BCL2 protein (18% positivity and generally weak). These data are consistent with the previously published studies in which BCL2 positivity was reported to be 25% to 55%. 3, 4 Although advanced disease at presentation and resistance to combination chemotherapy have been reported to be associated with BCL2 expression, 3 a relationship between BCL2 expression and clinical stage or outcome was not observed in our study. The PFL patients in our series consistently presented with early clinical stage (I or II), and all achieved complete remission without recurrence during the available clinical follow-up. Our data are in keeping with another recently published study. 4 Earlier studies also have demonstrated the lack of t(14;18) in PFL, 3,4 a finding confirmed in our series.
The distinction between PFL and PNMZL also can be problematic, given the overlapping features of these 2 entities. However, characteristic features seen in PNMZL, 9 such as expanded interfollicular areas by B cells and progressive transformation of germinal center-like changes, were usually absent in PFL cases. Residual hyperplastic germinal centers may be present and show the expected cytologic composition and polarization. PD-1, a member of the CD28 costimulatory receptor family, is expressed by follicular helper T cells. 23 We sought to use the PD-1 staining pattern to help distinguish PFL and PNMZL. Overall, the abnormal follicles of nodal PFL contained fewer PD-1-positive T cells compared with the disrupted follicles of the PNMZL cases. In addition, the distribution of the PD-1-positive lymphocytes was abnormal in nodal PFL, being pushed to the peripheral rim of the atypical follicles. Muenst et al 24 also studied the distribution of PD-1-positive lymphocytes in B-cell lymphomas. They observed fewer PD-1-positive lymphocytes in grade 3 FLs as compared with grade 1-2 FLs, in keeping with our observations, but their study did not include nodal marginal zone lymphoma.
Utilizing the published and expanded criteria for the diagnosis of PFL and UFL, the lymph nodes involved by FL in patients under the age of 30 clearly segregate into 2 groups. UFL was not observed in patients under the age of 18 and is much more likely to present with disseminated disease. In addition, the data in our study indicate substantial differences in PFL involving the Waldeyer ring from those presenting in the lymph nodes or testes. Upregulation of MUM1 expression and/or IRF4 breaks imply a possible pathogenetic mechanism for PFL located in the Waldeyer ring. A prior publication 25 had emphasized the unique features of testicular FL, which rarely, if ever, show evidence of extratesticular disease.
Correct diagnosis of FL in these patients requires careful examination of histologic, immunophenotypic, cytogenetic, and clinical features, but the optimal clinical management is still unresolved. Although monoclonality is demonstrated for these lesions, many cases appear to have a very limited potential for progressive disease. There is an increasing recognition in the literature of clonal lymphoid proliferations with limited potential for clinical aggressiveness. 26 In the future, nodal and testicular PFLs may be grouped with other clonal B-cell proliferations of undetermined significance, such as monoclonal gammopathy of undetermined significance, FL in situ, and mantle cell lymphoma in situ. 26, 27 However, as PFLs involving the Waldeyer ring are associated with a recurrent cytogenetic abnormality, they may have potential for a more aggressive clinical course.
